JP2006502132A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006502132A5 JP2006502132A5 JP2004527017A JP2004527017A JP2006502132A5 JP 2006502132 A5 JP2006502132 A5 JP 2006502132A5 JP 2004527017 A JP2004527017 A JP 2004527017A JP 2004527017 A JP2004527017 A JP 2004527017A JP 2006502132 A5 JP2006502132 A5 JP 2006502132A5
- Authority
- JP
- Japan
- Prior art keywords
- warm
- human
- pharmaceutical composition
- ionizing radiation
- blooded animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0218525A GB0218525D0 (en) | 2002-08-09 | 2002-08-09 | Combination therapy |
| GB0307560A GB0307560D0 (en) | 2003-04-02 | 2003-04-02 | Combination therapy |
| PCT/GB2003/003388 WO2004014383A1 (en) | 2002-08-09 | 2003-08-05 | Combination of zd6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006502132A JP2006502132A (ja) | 2006-01-19 |
| JP2006502132A5 true JP2006502132A5 (https=) | 2006-09-07 |
Family
ID=31716921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004527017A Pending JP2006502132A (ja) | 2002-08-09 | 2003-08-05 | 癌の治療における血管内皮細胞増殖因子受容体の阻害薬ｚｄ６４７４と放射線療法との併用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050222183A1 (https=) |
| EP (1) | EP1534287A1 (https=) |
| JP (1) | JP2006502132A (https=) |
| KR (1) | KR20050056190A (https=) |
| CN (1) | CN1313094C (https=) |
| AU (1) | AU2003249000B2 (https=) |
| BR (1) | BR0313116A (https=) |
| CA (1) | CA2495487A1 (https=) |
| IL (1) | IL166522A0 (https=) |
| MX (1) | MXPA05001458A (https=) |
| NO (1) | NO20050450L (https=) |
| NZ (1) | NZ537753A (https=) |
| WO (1) | WO2004014383A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ301689B6 (cs) | 1999-11-05 | 2010-05-26 | Astrazeneca Ab | Derivát chinazolinu a farmaceutický prostredek, který ho obsahuje |
| GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
| ES2267748T3 (es) | 2000-04-07 | 2007-03-16 | Astrazeneca Ab | Compuestos de quinazolina. |
| GB0126879D0 (en) * | 2001-11-08 | 2002-01-02 | Astrazeneca Ab | Combination therapy |
| JP4608215B2 (ja) * | 2002-02-01 | 2011-01-12 | アストラゼネカ アクチボラグ | キナゾリン化合物 |
| GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
| GB0223380D0 (en) * | 2002-10-09 | 2002-11-13 | Astrazeneca Ab | Combination therapy |
| RU2350618C2 (ru) | 2002-11-04 | 2009-03-27 | Астразенека Аб | ПРОИЗВОДНЫЕ ХИНАЗОЛИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Src ТИРОЗИНКИНАЗЫ |
| PT1592423E (pt) * | 2003-02-13 | 2011-06-16 | Astrazeneca Ab | Terapia de combinação de zd6474 com 5-fu e/ou cpt-11 |
| GB0310401D0 (en) * | 2003-05-07 | 2003-06-11 | Astrazeneca Ab | Therapeutic agent |
| EP1648465B1 (en) * | 2003-07-10 | 2010-08-25 | AstraZeneca AB | Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| KR20070072543A (ko) * | 2004-09-27 | 2007-07-04 | 아스트라제네카 아베 | Ｚｄ6474 및 이마티닙을 포함하는 병합법 |
| GB0424339D0 (en) * | 2004-11-03 | 2004-12-08 | Astrazeneca Ab | Combination therapy |
| GB0519879D0 (en) | 2005-09-30 | 2005-11-09 | Astrazeneca Ab | Chemical process |
| WO2007071958A2 (en) * | 2005-12-22 | 2007-06-28 | Astrazeneca Ab | Combination of zd6474 and pemetrexed |
| JP4945133B2 (ja) * | 2006-01-19 | 2012-06-06 | 富士フイルムＲｉファーマ株式会社 | ４−フェノキシキナゾリン誘導体放射性化合物 |
| EP2066353B1 (en) * | 2006-09-29 | 2013-01-02 | AstraZeneca AB | Combination of zd6474 and bevacizumab for cancer therapy |
| US20080190689A1 (en) * | 2007-02-12 | 2008-08-14 | Ballard Ebbin C | Inserts for engine exhaust systems |
| WO2009118560A1 (en) * | 2008-03-28 | 2009-10-01 | Astrazeneca Ab | Combination therapy 038 |
| CN106317022A (zh) * | 2015-06-25 | 2017-01-11 | 中美华世通生物医药科技（武汉）有限公司 | 化合物的制备方法和用途 |
| CN106397401B (zh) * | 2016-08-30 | 2018-11-13 | 山东罗欣药业集团股份有限公司 | 一种抗癌药物的晶体化合物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ301689B6 (cs) * | 1999-11-05 | 2010-05-26 | Astrazeneca Ab | Derivát chinazolinu a farmaceutický prostredek, který ho obsahuje |
-
2003
- 2003-08-05 KR KR1020057002082A patent/KR20050056190A/ko not_active Ceased
- 2003-08-05 CA CA002495487A patent/CA2495487A1/en not_active Abandoned
- 2003-08-05 JP JP2004527017A patent/JP2006502132A/ja active Pending
- 2003-08-05 MX MXPA05001458A patent/MXPA05001458A/es unknown
- 2003-08-05 NZ NZ537753A patent/NZ537753A/en unknown
- 2003-08-05 WO PCT/GB2003/003388 patent/WO2004014383A1/en not_active Ceased
- 2003-08-05 EP EP03784247A patent/EP1534287A1/en not_active Withdrawn
- 2003-08-05 BR BR0313116-5A patent/BR0313116A/pt not_active IP Right Cessation
- 2003-08-05 AU AU2003249000A patent/AU2003249000B2/en not_active Ceased
- 2003-08-05 US US10/523,832 patent/US20050222183A1/en not_active Abandoned
- 2003-08-05 CN CNB038191016A patent/CN1313094C/zh not_active Expired - Fee Related
-
2005
- 2005-01-26 IL IL16652205A patent/IL166522A0/xx unknown
- 2005-01-26 NO NO20050450A patent/NO20050450L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006502132A5 (https=) | ||
| JP2024133475A5 (https=) | ||
| JP2006500346A5 (https=) | ||
| JP2024133474A5 (https=) | ||
| JP2018109022A5 (https=) | ||
| JP2015523397A5 (https=) | ||
| CA2531862A1 (en) | Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability | |
| JP2006501147A5 (https=) | ||
| JP2003528917A5 (https=) | ||
| NO20014842D0 (no) | Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft | |
| WO2004043389B1 (en) | Methods of treating cancer and related methods | |
| JP2006508953A5 (https=) | ||
| CY1110305T1 (el) | Μεθοδοι για την προληψη και θεραπευτικη αντιμετωπιση της μεταστασης καρκινου και της οστικης απωλειας που συνδεεται με τη μετασταση καρκινου | |
| BRPI0406667A (pt) | Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg | |
| JP2008514577A5 (https=) | ||
| JP2005511597A5 (https=) | ||
| RU2012148710A (ru) | Органическое соединение для применения при лечении рака печени | |
| CA2514227A1 (en) | Combination therapy of zd6474 with 5-fu or/and cpt-11 | |
| JP2019533684A5 (https=) | ||
| AR037346A1 (es) | Terapia de combinacion | |
| WO2006110175A3 (en) | Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor | |
| JP2006513184A5 (https=) | ||
| DE602004016376D1 (de) | Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs | |
| JP2014534229A5 (https=) | ||
| JP2005530735A5 (https=) |